

Course Description
Contrast-enhanced breast MRI (CE-MRI) is an important tool for diagnosing and managing patients with breast cancer. It is most often used to determine how far the cancer has spread locally, to screen high-risk patients, monitor treatment response, and assess any issues with breast implants. Gadolinium (Gd)-based contrast agents (GBCAs) improve MRI quality by making tumors easier to identify and showing structural details and blood-flow changes linked to tumor growth. CE-MRI also has some limitations, including high cost, limited availability, longer scan times, and concerns regarding the retention of Gd in the body. As a result, safer and more effective contrast agents are being developed, and new imaging methods, including dynamic CE-MRI and diffusion-weighted imaging, have improved staging accuracy and treatment planning. Developing and employing abbreviated breast MRI protocols is also ongoing, which are designed to reduce imaging costs and scan time, making breast MRI more accessible to all. This course will review breast MRI imaging protocols and strategies, dynamic contrast-enhanced MRI, and abbreviated breast MRI protocols, as well as provide a detailed review of current and new GBCAs used in breast CE-MRI, as well as the benefits and drawbacks.
Learning Objectives
After reviewing the content, the participant should be able to:
Categories: MRI & Imaging Assistant, MR

In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.
Submit the completed answers to determine if you have passed the post-test assessment. You must answer 8 out of 10 questions correctly to receive your CE credit. You will have no more than 3 attempts to successfully complete the post-test.
Participants successfully completing the activity content and passing the post-test will receive 1.0 ARRT Category A credit.
Approved by the American Society of Radiologic Technologists for ARRT Category A credit.
Approved by the state of Florida for ARRT Category A credit.
Texas direct credit.
This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

| Category | Content Area | Credits |
|---|---|---|
| Magnetic Resonance | Patient Care | 0.75 |
| Radiologist Assistant | Patient Care | 0.75 |
| Vascular Interventional | Patient Care | 0.25 |

| Category | Subcategory | Credits |
|---|---|---|
| Magnetic Resonance | Patient Interactions and Management | 0.75 |
| Radiologist Assistant | Pharmacology | 0.75 |
| Vascular Interventional | Patient Interactions and Management | 0.25 |

| Category | Credits |
|---|---|
| Digital | 0 |
| Fluoroscopy | 0 |
| Mammography | 0 |

| Category | Content Area | Credits |
|---|---|---|
| IA MR | Patient Care | 0.75 |
Filippo Pesapane; Adriana Sorce; Ottavia Battaglia; Carmen Mallardi; Luca Nicosia; Luciano Mariano; Anna Rotili; Valeria Dominelli; Silvia Penco; Francesca Priolo; Gianpaolo Carrafiello; and Enrico Cassano
ABSTRACT
Contrast-enhanced breast MRI (CE-MRI) is an important tool for diagnosing and managing patients with breast cancer. It is most often used to determine how far the cancer has spread locally, to screen high-risk patients, monitor treatment response, and assess any issues with breast implants. Gadolinium (Gd)-based contrast agents (GBCAs) improve MRI quality by making tumors easier to identify and showing structural details and blood-flow changes linked to tumor growth. CE-MRI also has some limitations, including high cost, limited availability, longer scan times, and concerns regarding the retention of Gd in the body. As a result, safer and more effective contrast agents are being developed, and new imaging methods, including dynamic CE-MRI and diffusion-weighted imaging, have improved staging accuracy and treatment planning. Developing and employing abbreviated breast MRI protocols is also ongoing, which are designed to reduce imaging costs and scan time, making breast MRI more accessible to all. This course will review breast MRI imaging protocols and strategies, dynamic contrast-enhanced MRI, and abbreviated breast MRI protocols, as well as provide a detailed review of current and new GBCAs used in breast CE-MRI, as well as the benefits and drawbacks.
EDITORIAL NOTE: This article is an Open Access article reused under the terms and conditions of the Creative Commons Attribution (CC BY) license 4.0 (https://creativecommons.org/licenses/by/4.0/).
Original publication: Pesapane F, Sorce A, Battaglia O, et al. Contrast agents in breast MRI: state of the art and future perspectives. Biomedicines. 2025;13:829.
* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.
Enter your email address to receive our new course alerts.